Title	Publication Date	Language	Citations
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis	2010/06/18	English	956
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?	2019/06/18	English	576
Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression	2007/07/23	English	545
Epithelial–mesenchymal transition in cancer development and its clinical significance	2010/01/29	English	535
Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1	2004/01/01	English	531
A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate	2003/11/01	English	503
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish	2004/04/01	English	449
Oncolytic virus therapy: A new era of cancer treatment at dawn	2016/09/09	English	446
Regulation of cancer cell motility through actin reorganization	2005/07/01	English	443
Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer	2007/09/20	English	440
Reduced expression of Dicer associated with poor prognosis in lung cancer patients	2005/02/01	English	406
Emerging roles of long non‐coding RNA in cancer	2018/06/28	English	402
Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis	2004/05/01	English	397
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage	2004/11/01	English	394
Cancer/testis (CT) antigens: Potential targets for immunotherapy	2009/10/11	English	391
ADAMs in cancer cell proliferation and progression	2007/03/09	English	381
Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles	2009/03/30	English	379
Bystander killing effect of DS‐8201a, a novel anti‐human epidermal growth factor receptor 2 antibody–drug conjugate, in tumors with human epidermal growth factor receptor 2 heterogeneity	2016/06/22	English	377
Clinical significance of macrophage heterogeneity in human malignant tumors	2013/11/29	English	377
Role of iron in carcinogenesis: Cancer as a ferrotoxic disease	2009/01/01	English	372
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal	2003/01/01	English	369
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity in vitro and in vivo	2011/05/09	English	348
Tumor‐derived spheroids: Relevance to cancer stem cells and clinical applications	2017/03/01	English	312
Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins	2007/07/23	English	312
Cell adhesion system and human cancer morphogenesis	2003/07/01	English	304
Epidemiology of cholangiocarcinoma: An update focusing on risk factors	2010/02/17	English	296
Functional roles of N‐glycans in cell signaling and cell adhesion in cancer	2008/05/19	English	295
Genetic alterations and signaling pathways in the evolution of gliomas	2009/11/11	English	286
Lipoxygenase‐mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3	2017/09/15	English	280
Tumor hypoxia: A target for selective cancer therapy	2003/12/01	English	274